Gores closes buyout of blood cancer device firm

The Gores Group has finalized its buyout of Therakos, a maker of systems for treating blood cancer as well as devices for patients with immune disorders. Gores acquired Therakos from Ortho-Clinical Diagnostics, a unit of Johnson & Johnson.

View Full Article in:

Los Angeles Business Journal (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC